More SEC Filings

View Older Stories View Newer Stories

Jul 24, 2026 06:00AM Form D/A JMATT3X, LLC

Jul 24, 2026 06:00AM Form 6-K AXIA Energia S.A. For: Sep 30

Jul 24, 2026 06:00AM Form D Unless LGH Holdings LLC

Jul 24, 2026 06:00AM Form D Banter Capital Opportuni

Jul 24, 2026 06:00AM Form 485BPOS Northern Lights Fund

Jul 24, 2026 06:00AM Form 6-K AXIA Energia S.A. For: Sep 30

Jul 24, 2026 06:00AM Form 13F-HR ORBA Wealth Advisors, For: Jun 30

Jul 24, 2026 06:00AM Form 6-K AXIA Energia S.A. For: Sep 30

Jul 24, 2026 06:00AM Form N-23C-2 Calamos Dynamic Converti For: Jul 24

Jul 24, 2026 06:00AM Form N-23C-2 CALAMOS CONVERTIBLE & For: Jul 24

Jul 24, 2026 06:00AM Form N-23C-2 CALAMOS STRATEGIC TOTAL For: Jul 24

Jul 24, 2026 06:00AM Form N-23C-2 CALAMOS GLOBAL TOTAL For: Jul 24

Jul 24, 2026 06:00AM Form FWP HSBC USA INC /MD/ Filed by: HSBC USA INC /MD/

Jul 24, 2026 06:00AM Form SC TO-I/A Zoomcar Holdings, Inc. Filed by: Zoomcar Holdings, Inc.

Jul 24, 2026 06:00AM Form N-23C-2 CALAMOS CONVERTIBLE OPPO For: Jul 24

Jul 24, 2026 06:00AM Form 497 PROSHARES TRUST

Jul 23, 2026 09:55PM Form 4 Viant Technology Inc. For: Jul 21 Filed by: Vanderhook Timothy

Jul 23, 2026 09:54PM Form 4 Viant Technology Inc. For: Jul 21 Filed by: Vanderhook Christopher

Jul 23, 2026 09:54PM Form 4 Viant Technology Inc. For: Jul 21 Filed by: Capital V LLC

Jul 23, 2026 09:45PM Form 3 Scribe Therapeutics, For: Jul 23 Filed by: ELI LILLY & Co

Jul 23, 2026 09:43PM Form 4 Joint Stock Co Kaspi.kz For: Jul 21 Filed by: Kim Vyacheslav

Jul 23, 2026 09:33PM Form 3 Scribe Therapeutics, For: Jul 23 Filed by: ORBIMED ADVISORS LLC

Jul 23, 2026 09:33PM Form 3 Scribe Therapeutics, For: Jul 23 Filed by: Andreessen Marc L

Jul 23, 2026 09:30PM Form 4 Fold Holdings, Inc. For: Jul 22 Filed by: McManus Matt

Jul 23, 2026 09:28PM Form 3 Scribe Therapeutics, For: Jul 23 Filed by: Staahl Brett

Jul 23, 2026 09:27PM Form 3 Scribe Therapeutics, For: Jul 23 Filed by: Doudna Jennifer A

Jul 23, 2026 09:26PM Form 3 Scribe Therapeutics, For: Jul 23 Filed by: GORDON CARL L

Jul 23, 2026 09:24PM Form 3 Scribe Therapeutics, For: Jul 23 Filed by: Watson James Dean

Jul 23, 2026 09:23PM Form SCHEDULE 13D/A Artiva Biotherapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.

Jul 23, 2026 09:23PM Form 4 Artiva Biotherapeutics, For: Jul 21 Filed by: RA Capital Healthcare Fund LP

Jul 23, 2026 09:22PM Form 3 Scribe Therapeutics, For: Jul 23 Filed by: Lucas Svetlana

Jul 23, 2026 09:21PM Form 4/A Artiva Biotherapeutics, For: Jul 13 Filed by: RA Capital Healthcare Fund LP

Jul 23, 2026 09:21PM Form 3 Scribe Therapeutics, For: Jul 23 Filed by: Oakes Benjamin L.

Jul 23, 2026 09:19PM Form 3 Scribe Therapeutics, For: Jul 23 Filed by: Bleharski Joshua

Jul 23, 2026 09:18PM Form 3 Scribe Therapeutics, For: Jul 23 Filed by: Parrot David

Jul 23, 2026 09:09PM Form SCHEDULE 13G Rare Earths Americas, Filed by: Allen Dominic Paul

Jul 23, 2026 09:00PM Form 3 Scribe Therapeutics, For: Jul 23 Filed by: Avoro Capital Advisors LLC

Jul 23, 2026 08:55PM Form 4 CADENCE DESIGN SYSTEMS For: Jul 22 Filed by: TENG CHIN-CHI

Jul 23, 2026 08:45PM Form SCHEDULE 13G/A Robinhood Ventures Fund Filed by: Robinhood Markets, Inc.

Jul 23, 2026 08:31PM Form SCHEDULE 13D/A Brookfield Infrastructur Filed by: BROOKFIELD Corp /ON/

Jul 23, 2026 08:31PM Form 4 StoneX Group Inc. For: Jul 22 Filed by: Rotsztain Diego

Jul 23, 2026 08:31PM Form 4 StoneX Group Inc. For: Jul 22 Filed by: OCONNOR SEAN MICHAEL

Jul 23, 2026 08:30PM Form 4 StoneX Group Inc. For: Jul 22 Filed by: Dunaway William J

Jul 23, 2026 08:30PM Form SCHEDULE 13D/A Brookfield Infrastructur Filed by: BROOKFIELD Corp /ON/

Jul 23, 2026 08:30PM Form 4 StoneX Group Inc. For: Jul 22 Filed by: Smith Philip Andrew

Jul 23, 2026 08:29PM Form 4 StoneX Group Inc. For: Jul 22 Filed by: Maurer Mark Lowry

Jul 23, 2026 08:21PM Form 4 SCHOLASTIC CORP For: Jul 21 Filed by: Peter Warwick

Jul 23, 2026 08:02PM Form 4 CoreWeave, Inc. For: Jul 21 Filed by: Intrator Michael N

Jul 23, 2026 07:56PM Form 144 RADCOM LTD Filed by: Lynrock Lake Master Fund LP

Jul 23, 2026 07:50PM Form 4 Outlook Therapeutics, For: Jul 21 Filed by: KENYON LAWRENCE A

View Newer Stories View Older Stories